Loading…
This event has ended. View the official site or create your own event → Check it out
This event has ended. Create your own
Take Your Nursing Practice to the Next Level
View analytic
Saturday, April 25 • 9:30am - 10:30am
REVLIMID® (lenalidomide) Treatment for Patients With Deletion 5q Myelodysplastic Syndromes: A Nurse’s Perspective FULL

Sign up or log in to save this to your schedule and see who's attending!

Limited Capacity full
Adding this to your schedule will put you on the waitlist.

Please join us for a Celgene presentation of REVLIMID® in the treatment of del(5q) Myelodysplastic Syndromes.  Sandra Kurtin, RN, MS, AOCN, ANP-C from The University of Arizona Cancer Center will walk you through an overview of the MDS, discuss considerations for the treatment of patients with MDS, present patient cases, and review the use of REVLIMID and important safety information. We are looking forward to your attendance.  

This program is sponsored by Celgene Corporation.  

Speakers
avatar for Sandra Kurtin RN, MS, AOCN®, ANP-C

Sandra Kurtin RN, MS, AOCN®, ANP-C

Hematology/Oncology Nurse Practitioner, Clinical Assistant Professor of Nursing, Clinical Assistant Professor of Medicine, Arizona Cancer Center, University of Arizona
Sandra E. Kurtin, RN, MS, AOCN, ANP-C graduated from the University of Arizona with a Bachelor of Science in Nursing with high distinction, followed by a Master of Science in Oncology Nursing and post-graduate certification in both Geriatric and Adult Practice.  She is currently employed as a hematology/oncology Nurse Practitioner at the University of Arizona Cancer Center, and serves as an Adjunct Clinical Assistant Professor of Nursing... Read More →


Saturday April 25, 2015 9:30am - 10:30am
Learning Hall Theater 1 9800 International Drive, Orlando, FL 32819